activity against gramnegative bacteria p aeruginosa (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
activity against gramnegative bacteria p aeruginosa
Activity Against Gramnegative Bacteria P Aeruginosa, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activity+against+gramnegative+bacteria+p+aeruginosa/Pseudomonas+aeruginosa/pm35339840-95-25-31
Average 95 stars, based on 122 article reviews
Activity Against Gramnegative Bacteria P Aeruginosa, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activity+against+gramnegative+bacteria+p+aeruginosa/Pseudomonas+aeruginosa/pm35339840-95-25-31
Average 95 stars, based on 122 article reviews
activity against gramnegative bacteria p aeruginosa - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Activity Assay:Article Title: Amphiphilic cyclic peptide [W 4 KR 5 ]-Antibiotics combinations as broad-spectrum antimicrobial agents. Article Snippet: Linear and cyclic amphiphilic peptides, (W4KR5) and [W4KR5], were evaluated as antibacterial agents against Gram-positive and Gram-negative bacteria, including four multi-drug resistant strains and the corresponding four non-resistant strains.. Cyclic peptide [W4KR5] showed higher antibacterial activity than the linear (W4KR5) counterpart.. Cyclic [W4KR5] was subjected to combination (physical mixture or covalent conjugation) with meropenem as a model antibiotic to study the impact of the combination on antimicrobial activity. Bacteria:Article Title: Amphiphilic cyclic peptide [W 4 KR 5 ]-Antibiotics combinations as broad-spectrum antimicrobial agents. Article Snippet: Linear and cyclic amphiphilic peptides, (W4KR5) and [W4KR5], were evaluated as antibacterial agents against Gram-positive and Gram-negative bacteria, including four multi-drug resistant strains and the corresponding four non-resistant strains.. Cyclic peptide [W4KR5] showed higher antibacterial activity than the linear (W4KR5) counterpart.. Cyclic [W4KR5] was subjected to combination (physical mixture or covalent conjugation) with meropenem as a model antibiotic to study the impact of the combination on antimicrobial activity. |